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Abstract: Population-based newborn screening (NBS) using blood collected and dried on filter
paper was developed in the 1960s and remains the international standard for NBS programs. Glue,
used in the manufacture of dried blood collection cards, may present a source of contamination
and is often considered as a possible cause of anomalous results in routine screening. Our study
evaluates this potential contamination on NBS analyses. EBF#1003 glue was blotted onto dried
blood collection cards made of Whatman grade 903 filter paper (Whatman#903) and adult whole
blood was pipetted onto the dried glue blots. In addition, blank glue blots (i.e., no blood) and dried
blood spots (DBSs) in the absence of glue were prepared. The DBSs and blank samples were run
in duplicate as routine samples for NBS. DBS absorption time and diameter, the effect of glue on
measurements (concentrations and variation) were assessed. DBS absorption time and shape were
equivalent for DBSs prepared in the absence and presence of undiluted glue. DBS diameter increased
when prepared in the presence of glue. When EBF#1003 was diluted prior to use, DBS absorption
time increased, and DBSs were non-uniform. Glue, diluted or not, did not produce measurements
above the established Limit of Detection (LOD) for all assays used in the current Dutch screening
programme. For all analytes with concentrations in the quantifiable range, contamination with glue
had no effect on measurement variation, as it appeared equivalent to variation in untreated DBSs.
Our data show that, in the unlikely event of contamination of Whatman#903 with EBF#1003, there is
no effect on the measured concentration of analytes.
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1. Introduction
The Dutch neonatal screening (NBS) programme, started in 1974, currently screens for 19 diseases:
conducted in five laboratories, it is available to all babies born in The Netherlands and uses the
filter paper card often referred to as a “Guthrie Card”. As with all methods of blood collection,
there is associated imprecision and variability with the use of filter papers, for example, the variable
distribution of analytes in the dried blood spot (DBS) (the “chromatography effect”), blood absorption
time, contamination, and the filter paper matrix, which can all have an influence on the recovery
of analytes [1,2]. For this reason, approved standards for the manufacture of filter paper for NBS
purposes are available [3]. Transitions between filter paper types and filter paper lots should be
minimized, but are inevitable. In 2016, the heel prick filter card used in the Dutch NBS programme,
PerkinElmer grade 226 filter paper (PerkinElmer#226), was replaced by Whatman grade 903 filter
paper (Whatman#903). A verification study has been conducted in our laboratory to assess the effect
this change would have on NBS analysis; the results illustrate that the two filter papers are essentially
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equivalent, an observation which concurs with a previous study comparing PerkinElmer#226 and
Whatman#903 [4]. Glue, used in the manufacture of heel prick cards, anecdotally has been considered
a cause for unexplained high measurement levels in NBS and is assumed to interfere with the
measurements of analytes. However, there are no published studies that we are aware of that evaluate
this effect. As part of the verification study for Whatman#903, the manufacturer of the cards uniquely
enabled us to evaluate the effect of glue contamination on NBS analysis and to state that the chances of
glue contamination in the production process are extremely small. Below, we present the effect of glue
on the measurements of analytes employed in Dutch newborn heel prick screening, tested as glue on
filter paper and in combination with DBSs, evaluating multiple assays and multiple analytes.
2. Materials and Methods
Whatman#903 and the EBF#1003 glue used in the manufacture of Whatman#903 were provided
by Eastern Business Forms, Inc., Mauldin, SC, USA.
2.1. Preparation of Glue
In order to assess whether any observed effects are dependent on the concentration of glue,
three concentrations of glue were prepared to provide a range of quantifiable glue concentrations:
undiluted, 1:1 diluted with demineralized water, and 1:4 diluted with demineralized water.
2.2. Preparation of Glued Filter Paper
For each of the three concentrations of glue: 15 µL of glue was pipetted onto a plastic template
(12 mm × 22 mm) and evenly spread using a plastic spatula. The template was blotted onto the filter
paper and held in place for 5 s before removing.
2.3. Preparation of DBSs on Filter Paper Treated with Glue
Adult whole blood was collected in a lithium heparin vacutainer and 50 µL was pipetted on filter
paper treated with glue for each of the glue concentrations. DBSs were also prepared on filter paper not
treated with glue, “untreated filter paper”. The filter paper was dried on a horizontal, non-absorbent
surface for at least 3 h at ambient temperature [5]. For the duration of the study, the filter paper was
stored at ambient temperature.
Absorption times and absorption diameters were recorded for each glue concentration.
Absorption time was measured with a stopwatch, which was started when the blood touched the
filter paper and stopped when any shine from the liquid blood was no longer visible on the surface.
Absorption diameters were measured at the widest diameter [6].
2.4. Analysis of DBSs
Punches (3.2 mm) were obtained from the various combinations of DBSs and glue-treated filter
paper and run in duplicate as routine samples for all routine NBS analyses conducted in the Dutch
NBS programme (see Table 1 for overview), assessing the concentration of a total of 28 analytes. Due to
practical constraints, Total Galactose (TGAL) and Thyroid Stimulating Hormone (TSH) analyses were
not included in this study. Interference and carryover were also assessed.
The presented results are the DBS absorption characteristics (Table 2) and concentrations of
analytes, when exceeding the Limit of Detection (LOD) values internally applied by our laboratory
(Table 3). Variation is expressed as standard deviation of the mean (SD) and as coefficient of variance
(%CV). Measured analyte concentrations of DBSs prepared on filter paper treated with glue are also
expressed as a percentage of concentrations in DBSs on untreated filter paper (Table 4).
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Table 1. Analytical methods employed and analytes measured within the Dutch Newborn Screening
(NBS) programme, and for which the effect of glue was evaluated (RIVM: reference laboratory for
neonatal screening).
Analytical Instrument Analyte




Thyroid Stimulating Hormone (TSH) *
Galactose-1-Phosphate Uridyltransferase (GALT)
Immunoreactive Trypsinogen (IRT)
Waters Quattro Micro tandem mass spectrometer (MS/MS)
with Neobase Non-derivatized MS/MS assay with Neobase
Succinylacetone Assay Solution (PerkinElmer)
Amino Acids (Leu, Phe, Tyr, Val) and
acylcarnitines (C0, C2, C5, C5DC, C6, C8, C10,
C10:1, C14, C14:1, C14:2, C16, C16:1, C16:1-OH,
C18:1-OH, SA)
HPLC (Bio-Rad VARIANTnbs Sickle Cell Program) Hemoglobins (Hb)
Anthos-Zenyth 340r photometer (filters 540/690) with
Bio-Rad Quantase kit Biotinidase (BIOT)
Anthos-Zenyth 340r photometer (filters 570/690) with
Bio-Rad Quantase kit Total Galactose (TGAL) *
Anthos-Zenyth 340r photometer (filters 450/620) with
Monobind Accubind ELISA Thyroxine binding globulin (TBG)
PerkinElmer Delfia 1234 fluorometer with dynabio
MucoPAP-F kit Pancreatitis Associated Protein (PAP)
* TSH and TGAL were not evaluated in this study.
3. Results
3.1. Absorption time and Absorption Diameter
The absorption times of DBS specimens prepared in the absence and presence of undiluted glue
are equivalent. DBS diameter shows an increase of 17% when prepared in the presence of undiluted
glue (Table 2). An increase in absorption time and absorption diameter of approximately 80% and 20%,
respectively, is associated with dilution of the glue with demineralized water (1:1 and 1:4 dilutions).
The observed increases in absorption time and absorption diameter are independent of the level of
dilution. The DBSs prepared in the presence of diluted glue (at both concentrations) were non-uniform
in shape and non-uniform in blood distribution on the side of blood application, but appeared uniform
in color on the reverse side of the filter paper.
Table 2. Absorption time and absorption diameter for dried blood spots (DBSs) prepared in the
presence and absence of glue. Please check and confirm.
Absorption Characteristics DBS-No Glue DBS-Glue DBS-Glue (1:1) Glue (1:4)
Absorption time (s) 4.1 ± 0.7 (16.2) 4.2 ± 0.3 (7.7) 7.4 ± 1.0 (13.9) 7.8 ± 0.5 (6.8)
Diameter (mm) 11.5 ± 0.6 (5.0) 13.5 ± 0.6 (4.3) 14.0 ± 0.0 (0.0) 14 ± 0.0 (0.0)
Note: data presented is mean ± SD (%CV) of n = 4 individual measurements.
3.2. Measurements of Analytes in Filter Paper Treated with Glue
Measurements of analytes in filter paper treated with glue, but in the absence of DBSs,
are presented in Table 3. For almost all analytes, measurements in filter paper treated with glue
were either below the LOD established within our laboratory or below the LOD as stated in the kit
insert of the assay (PAP)—otherwise, there was no measurement signal (Hb peaks). For analytes
where an LOD was not defined, measured concentrations were close to zero. With the exception of SA,
none of the measurements in glue-treated paper produced values above those in untreated filter paper.
For SA, measurements in paper with glue were almost equal to those in untreated filter paper because
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of a high LOB (a result of high variation at low measured concetrations of SA). For GALT, quenching
of the signal by hemoglobin in the dried blood spot is essential, so no reliable measurement signal was
obtained in the absence of DBSs. No relation was observed between measurements and concentration
of the glue for any of the analytes available (Table 4).
Table 3. Concentrations of analytes in untreated filter paper (no DBSs) and filter paper treated with
glue (no DBSs) †.
Analyte Untreated Glue Undiluted Glue Diluted 1:1 Glue Diluted 1:4 Laboratory-Established LOD
OHP <LOD <LOD <LOD <LOD 0.5
T4 ND ND ND ND 10
TBG <LOD <LOD <LOD <LOD Not established
BIOT 2 + 1.4 2 + 1.4 2 + 1.4 2 + 1.4 Not established
GALT - - - - Not established
Hb-FAST No peak No peak No peak No peak Not established
Hb-F No peak No peak No peak No peak Not established
Hb-A No peak No peak No peak No peak Not established
Hb-E No peak No peak No peak No peak Not established
IRT <LOD <LOD <LOD <LOD 10
PAP <LOD assay 0.1 + 0 0.0 + 0.0 <LOD assay Not established
Leu <LOD <LOD <LOD <LOD 10
Phe <LOD <LOD <LOD <LOD 10
Tyr <LOD <LOD <LOD <LOD 40
Val <LOD <LOD <LOD <LOD 15
C0 <LOD <LOD <LOD <LOD 2
C2 <LOD <LOD <LOD <LOD 1.5
C5 <LOD <LOD <LOD <LOD 0.08
C5DC <LOD <LOD <LOD <LOD 0.25
C5-OH <LOD <LOD <LOD <LOD 0.25
C6 0 + 0 0 + 0 0 + 0 0 + 0 Not established
C8 <LOD <LOD <LOD <LOD 0.06
C10 <LOD <LOD <LOD <LOD 0.04
C10:1 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
C14 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
C14:1 <LOD <LOD <LOD <LOD 0.1
C14:2 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
C16 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
C16:1 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
C16:1-OH 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
C18:1-OH 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 0.0 + 0.0 Not established
SA <LOD <LOD <LOD <LOD 1.0
Note: TSH and TGAL data not determined; † Units in blood: OHP, T4, TBG, nmol/L; BIOT, % c.f. daily mean;
GALT, U/dL; IRT, µg/L; Leu, Phe, Tyr, Val, C0, C5-OH, C8, C14:1, C16:1-OH, µmol/L.
3.3. Interaction of Glue with DBSs
To assess the interaction of glue with the measurements of analytes in punches from DBSs,
DBSs were prepared on filter paper treated with glue and analyzed. Results from selected analytes,
for which measured concentrations were in the quantifiable range (and still reflecting the range of
analytes and methods used within the screening programme), are presented (Table 4).
Variation in duplicate measurements was comparable to the variation obtained with DBSs on
untreated filter paper for all analytes and, with the exception of OHP, was mostly well below the
highest variation observed, 22% (Table 4). The measured concentration of OHP in DBSs, prepared in
the presence of undiluted glue and glue diluted 1:4 with deionized water, is more than twice as high
as the measured concentration of OHP reported for a DBS prepared in the absence of glue.
Again, with the exception of OHP, for all the analytes and for all concentrations of glue,
the measured analyte concentrations were comparable to measurements using DBSs on untreated filter
paper, as illustrated by the percentages in italics in Table 4: measurements as expressed as a percentage
of the measurement in DBSs on untreated filter paper were all between 64% (C14:1, filter paper treated
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with glue diluted 1:4) and 129% (BIOT on filter paper treated with glue diluted 1:1) but were generally
around 100%, with no obvious indication of a relation with the concentration of glue.
Table 4. Concentrations of analytes determined from DBSs prepared on filter paper with glue †.
Analyte DBS-No Glue Glue Undiluted Glue Diluted (1:1) Glue Diluted (1:4)
OHP 0.35 ± 0.21 (60.6%) 0.78 ± 0.04 (4.6%) 0.48 ± 0.32 (67%) 0.73 ± 0.32 (43.9%)
221% 136% 207%
T4 42.9 ± 1.84 (4.3%) 47.3 ± 6.15 (13%) 37.1 ± 1.77 (4.8%) 35.6 ± 2.47 (7%)
110% 86% 83%
TBG 156 ± 1.41 (0.91%) 195 ± 12.4 (6.3%) 183 ± 22.3 (12.2%) 145 ± 17.7 (12.2%)
125% 117% 93%
BIOT 85.5 ± 7.78 (9.1%) 109 ± 23.3 (21.5%) 110 ± 4.24 (3.9%) 96 ± 19.8 (20.6%)
127% 129% 112%
GALT 16.2 ± 0.99 (6.1%) 19.8 ± 3.11 (15.7%) 17.6 ± 1.98 (11.2%) 16.3 ± 0.28 (1.7%)
122% 109% 101%
IRT 22.5 ± 0.71 (3.1%) 25.0 ± 0 (0%) 20.5 ± 0.71 (3.4%) 22.5 ± 0.71 (3.1%)
111% 91% 100%
PAP 2.58 ± 0.02 (0.91%) 2.95 ± 0.16 (5.6%) 3.02 ± 0.02 (0.8%) 2.70 ± 0.38 (14.0%)
103% 98% 99%
Leu 83.6 ± 3.49 (4.2%) 87.5 ± 1.51 (1.7%) 95.5 ± 1.14 (1.2%) 87.8 ± 6.11 (7%)
105% 114% 105%
Phe 32.6 ± 1.37 (4.2%) 35.1 ± 0.01 (0.02%) 37.3 ± 0.06 (0.2%) 35.0 ± 1.48 (4.2%)
108% 115% 107%
Tyr 31.7 ± 0.76 (2.4%) 33.5 ± 3.54 (10.6%) 35.8 ± 4.07 (11.4%) 32.9 ± 3.3 (10%)
106% 113% 104%
Val 96.6 ± 3.54 (3.7%) 99.4 ± 1.68 (1.7%) 112 ± 6.83 (6.1%) 101 ± 5.51 (5.4%)
103% 116% 105%
C0 19.2 ± 0.62 (3.2%) 19.5 ± 1.22 (6.3%) 21.8 ± 0.36 (1.7%) 19.7 ± 1.05 (5.3%)
101% 113% 103%
C5-OH 0.41 ± 0.04 (10.4%) 0.32 ± 0 (0%) 0.47 ± 0 (0%) 0.47 ± 0.08 (16.7%)
78% 115% 113%
C8 0.11 ± 0 (0%) 0.11 ± 0.02 (20.2%) 0.12 ± 0.01 (6.1%) 0.1 ± 0.01 (14.1%)
95% 105% 91%
C14:1 0.06 ± 0.01 (12.9%) 0.06 ± 0.01 (12.9%) 0.06 ± 0.01 (12.9%) 0.04 ± 0.01 (20.2%)
100% 100% 64%
C16:1-OH 0.01 ± 0 (0%) 0.01 ± 0 (0%) 0.01 ± 0 (0%) 0.01 ± 0 (0%)
100% 100% 100%
Note 1: Data presented is mean concentrations of duplicate measurements ± 1 SD (%CV). Note 2: Presented results
are from analytes for which measured concentrations were in the quantifiable range only. † Units in blood: OHP,
T4, TBG, nmol/L; BIOT, % c.f. daily mean; GALT, U/dL; IRT, µg/L; Leu, Phe, Tyr, Val, C0, C5-OH, C8, C14:1,
C16:1-OH, µmol/L. Concentrations are also expressed as percentage of concentrations in the absence of glue
(second line, italics).
4. Discussion
We have conducted an investigation into the effect of glue, used in the manufacture of
Whatman#903 NBS cards. This study has evaluated the effects on analytes measured as routine in the
Dutch NBS programme. Adult whole blood was used in this study without enrichment: for all markers
except OHP, analyte concentrations were in the quantifiable range, and for the majority of markers,
analyte concentrations were comparable to average concentrations detected in neonate samples
analyzed in our laboratory. Data from selected analytes, for which measured concentrations were in
the quantifiable range and which reflect the range of analytes and analytical methods, illustrate our
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findings. In these experiments, we simulated a situation where a considerable glue spill directly
contaminates the filter paper. Contamination of the filter paper with glue during the manufacturing
process is highly unlikely, especially at glue concentrations assessed in this work. These data indicate
that the presence of glue, at three concentrations at the upper limits of the risk spectrum, has no effect
on the measured concentrations of analytes employed in the Dutch NBS programme.
A logarithmic relationship between spot volume and spot diameter has previously been described,
and a DBS diameter of 11.5 mm was reported for a spot volume of 50 µL [4]. Our results for DBSs
on Whatman#903 concur with these data. However, our results show that the diameter of the
DBSs prepared in the presence of glue, undiluted and diluted, is approximately 20% larger than
the DBSs prepared in the absence of glue. An increase in spot diameter might be expected to reduce
analyte concentration, but in this study a corresponding, structural decrease in measured analyte
concentrations was not observed in the presence of undiluted glue.
DBSs prepared in the presence of undiluted glue were uniform in shape and blood distribution.
However, when the glue is diluted with demineralized water (1:1 and 1:4, glue/demineralized water),
the DBS is non-uniform with respect to shape and distribution of the blood on the filter paper. The CLSI
Approved Standard NBS01-A6 [5] states that the acceptable range for absorption of 100 µL blood is
5–30 s. If a linear relationship between blood volume and absorption time is assumed, then for 50 µL
an acceptable range for absorption time is 2.5–15 s. Our results for DBSs produced under all conditions
lie within these limits. DBSs produced in the absence of glue or in the presence of undiluted glue are
similar (4.06 s and 4.23 s, respectively). However, absorption time for DBSs produced in the presence
of diluted glue are markedly higher (80–90%). In addition, once absorbed, the distribution of the
glue on the filter paper was uneven. From these observations, it can be concluded that the property
of the glue and the manner in which the glue interacts with the filter paper is altered following the
addition of demineralized water. Upon mixture, the glue appeared to be miscible with demineralized
water; however, upon standing, two phases formed. It is possible that, because of the addition of
demineralized water to the glue, its physical properties change such that hydrophilic and hydrophobic
areas form when the glue is applied to the filter paper. A definitive conclusion for this effect cannot
be elucidated from this study and is beyond its scope. The study design included the dilution of
the glue with water to create different glue concentrations in order to determine if any effect of glue
contamination was proportional to the concentration of glue. However, since glue contamination at
the highest concentration (undiluted glue) had no effect on the measured concentration of analytes,
the proportional effects of different glue concentrations were of less relevance.
Interference has been assessed by comparison of results obtained from DBSs prepared in the
presence and absence of glue. No interference was identified for the analytes, analytical methods,
and instruments included in this study. The measured concentrations of OHP were close to the limit
of quantification (0.1 nmol/L) and were significantly higher in blood prepared in the presence of
glue (at all glue concentrations). This effect was not observed for analytes measured using similar
methods or instrumentation (T4, GALT, IRT), indicating that it is not the analytical method or analytical
instrument that is sensitive to the presence of glue. Adult blood was used to prepare the DBSs and
since OHP levels in blood from a healthy adult are typically less than half of the levels found in
a healthy neonate, it can be concluded that the low levels of OHP in the blood and the corresponding
high variability in the raw data have incidentally given rise to this effect.
5. Conclusions
In the process of producing heel prick cards using Whatman#903 and the EBF#1003 glue,
contamination of the filter paper with EBF#1003 glue is extremely unlikely. Contamination of filter
paper with undiluted glue should be apparent from a visual check of the card, but will not affect the
size or shape of a DBS. The data from this study show that the glue will not affect the results of NBS
analysis; therefore, contamination is unlikely to be responsible for unexplained deviant measurements
in routine neonatal screening.
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